EUVIMEDEUVIMED entdecken
BeobachtungsstudieValidierungsstudie

Indocyanine Green Clearance Test via Pulse Dye Densitometry for Portal Hypertension Diagnosis in cACLD

Miaoxia Liu, Xiaofeng Zhang iD, Xiao Cheng, Qinjun He, Tiantian Zhou iD, Haiyu Wang iD, Beiling Li, Wenfan Luo, Junying Li, Hui Li, Zimo Lin, Jiankang Song und 11 weitere

Liver International · 2025

DOI: 10.1111/liv.70425 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Liver International, 2025. Verfasst von Miaoxia Liu und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology Unit and Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Coloring Agents, Densitometry, Hypertension, Portal, Indocyanine Green. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Performance of pulse dye densitometry (PDD)‐estimated indocyanine green 15‐min retention rate (ICG‐R15) in the diagnosis of clinically significant portal hypertension (CSPH) has not been studied. A prospective compensated advanced chronic liver disease (cACLD) cohort was used to explore the capability of ICG‐R15 in the differentiation of CSPH as referenced by hepatic venous pressure gradient (HVPG). Patients and Methods Performance of ICG‐R15 alone and combined with Baveno VII algorithm for CSPH differentiation was established with a monocentric set and validated with a bicentric set of patients with HVPG assessment.

Results

In the training set ( n = 96), ICG‐R15 ≥ 14% could identify 63.6% (28/44) CSPH with 96.2% specificity and 93.3% positive predictive value (PPV). ICG‐R15 < 4% was able to exclude 40.4% (21/52) non‐CSPH with 95.5% sensitivity and 91.3% negative predictive value (NPV). In the validation set ( n = 106), ICG‐R15 ≥ 14% could identify 63.6% (28/44) CSPH with 95.2% specificity and 90.3% PPV. ICG‐R15 < 4% could exclude 41.9% (26/62) non‐CSPH with 95.5% sensitivity and 92.9% NPV. Sensitivity analysis in the total set of patients ( n = 202) reinforced robustness. Combined ICG‐R15 ≥ 14% with LSM ≥ 25 kPa improved performance with 72.7% (64/88) sensitivity, 85.3% PPV and 90.4% specificity. Meanwhile, ICG‐R15 < 4% with LSM ≤ 15 kPa plus platelet count ≥ 150 × 10 9 /L excluded CSPH with 95.5% sensitivity and 94.5% NPV, reducing diagnosis uncertainty (grey zone) to 26.7%.

Conclusion

PDD‐estimated ICG‐R15 ≥ 14% could identify CSPH and ICG‐R15 < 4% to exclude CSPH in cACLD patients. ICG‐R15 sequential with Baveno VII enhanced diagnostic capability, warranting multicentre validation. Trial Registration NCT04123509, NCT04820166 and NCT05251272

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coloring AgentsDensitometryHypertension, PortalIndocyanine GreenAdultAgedFemaleHumansMaleMiddle AgedAlgorithmsChronic DiseasePortal PressurePredictive Value of TestsProspective StudiesSensitivity and Specificity

Stichwörter der Autor:innen

clinically significant portal hypertensioncompensated advanced chronic liver diseaseindocyanine green clearance testpulse dye densitometry

Substanzen

Coloring AgentsIndocyanine Green

Autor:innen und Institutionen

  • Department of Hepatology Unit and Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Hepatology Unit, Zengcheng Branch, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Infectious Disease Department, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, China.
  • State Key Laboratory of Organ Failure Research, Guangzhou, China.
  • Key Laboratory of Infectious Diseases Research in South China, Ministry of Education, Guangzhou, China.
  • Guangdong Provincial Key Laboratory for Prevention and Control of Major Liver Diseases, Guangzhou, China.

ORCID-Profile: Xiaofeng Zhang, Tiantian Zhou, Haiyu Wang, Xiaoqin Luo, Jinjun Chen

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • National Science and Technology Major Project

Zitieren

APA

Liu, M., Zhang, X., Cheng, X., He, Q., Zhou, T., Wang, H., Li, B., Luo, W., Li, J., Li, H., Lin, Z., Song, J., Wang, W., Huang, J., Ji, Y., Zhou, D., Xie, W., Yang, Q., Tu, M., …, & Chen, J. (2025). Indocyanine Green Clearance Test via Pulse Dye Densitometry for Portal Hypertension Diagnosis in cACLD. Liver International. https://doi.org/10.1111/liv.70425

Vancouver

Liu M, Zhang X, Cheng X, He Q, Zhou T, Wang H, et al. Indocyanine Green Clearance Test via Pulse Dye Densitometry for Portal Hypertension Diagnosis in cACLD. Liver International. 2025. doi:10.1111/liv.70425

BibTeX
@article{Liu2025,
  author = {Liu, Miaoxia and Zhang, Xiaofeng and Cheng, Xiao and He, Qinjun and Zhou, Tiantian and Wang, Haiyu and Li, Beiling and Luo, Wenfan and Li, Junying and Li, Hui and Lin, Zimo and Song, Jiankang and Wang, Weibin and Huang, Jing and Ji, Yali and Zhou, Damei and Xie, Wanjun and Yang, Qiaolan and Tu, Minghan and Luo, Xiaoqin and Zhang, Xiaoyong and Yan, Huadong and Chen, Jinjun},
  title = {Indocyanine Green Clearance Test via Pulse Dye Densitometry for Portal Hypertension Diagnosis in cACLD},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.70425}
}
Kostenlos starten →